- Patent Title: Tumor antigen based on products of the tumor suppressor gene WT1
-
Application No.: US12181938Application Date: 2008-07-29
-
Publication No.: US09403886B2Publication Date: 2016-08-02
- Inventor: Haruo Sugiyama , Yoshihiro Oka
- Applicant: Haruo Sugiyama , Yoshihiro Oka
- Applicant Address: JP Suita-shi
- Assignee: INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC.
- Current Assignee: INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC.
- Current Assignee Address: JP Suita-shi
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P
- Priority: JP10-218093 19980731
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C07K14/47 ; C07K14/82 ; A61K38/00 ; A61K39/00
Abstract:
A tumor antigen that comprises, as an active ingredient, a product of the Wilms' tumor suppressor gene WT1 or a peptide composed of 7-30 contiguous amino acids containing an anchor amino acid for binding to major histocompatibility complex (MHC) class I in said amino acid sequence, and a vaccine comprising said antigen.
Public/Granted literature
- US20090143291A1 TUMOR ANTIGEN BASED ON PRODUCTS OF THE TUMOR SUPPRESSOR GENE WT1 Public/Granted day:2009-06-04
Information query
